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Abstract: Chronic fatiguesyndrome(CFS) ischaracterizedbyunexplained fatigue lasting formore than6monthsandaccompaniedbyflu-
like symptoms. It most commonly affects women aged between 30 and 60 years. To date, clear diagnostic criteria allowing for 
unambiguousdiagno-sisofCFShavenotbeenestablished.Wepresentacaseofa57-year-oldwomanwithchronicfatiguesyndrome
inordertoshowcasethesymptomsofthisconditionandproposeadiagnos-ticprotocol.
                   © Versita Sp. z o.o.
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1. Introduction
Fatigue constitutes a symptom reported in numerous 
diseases, including neurological condi-tions such as 
multiple sclerosis, Parkinson’s disease, vascular disor-
ders of the Central Nervous System (CNS), Lyme dis-
ease, lateral sclerosis, and post-polio syndrome, as well 
as in infectious, neoplastic and rheumatologic diseases. 
Chronic fatigue syndrome (CFS) is a condi-tion in which 
fatigue represents the main symptom. However, com-
prehensive examination and exclusion of other comor-
bidities is required prior to establishing the diagnosis of 
CFS [1-3].
 Chronic fatigue syndrome is characterized by unex-
plained fatigue persisting for longer than 6 months and 
associated with flu-like symptoms. US Centers for Dis-
ease Control (CDC) identi-fied this syndrome as a dis-
tinct entity for the first time in 1988. The diagnostic cri-
teria of CFS include major and minor symptoms. While 
the major symptoms refer to the presence of per-sistent 
or recurrent fatigue for at least 6 months in an individual 
who was not experienced similar signs in the past, the 
minor manifestations comprise sore throat, lymphade-
nopathy, muscular and joint pain, non-localized head-
aches of a new kind, impaired memory or concen-tra-
tion, and sleepiness or sleeplessness. Chronic Fatigue 
Syndrome also affects physical func-tioning and the 
emotional behavior of those affected. To date, clear di-
agnostic criteria allow-ing for unambiguous diagnosis of 
CFS have not been established [1-3].
 A UK study has revealed that signs of unexplained 
fatigue occur in 1 per 1000 individuals. American data 
estimates that there are as many as 17 million individu-
als worldwide suffering from CFS. However, the diag-
nosis of CFS is extremely rarely established amongst 
Polish patients. 
 Currently, CFS is poorly recognised, investigated 
and managed in Poland. This case study illustrates the 
complexity of this condition and emphasises the asso-
ciation with autonomic dysfunction [4].
 Chronic Fatigue Syndrome is a disorder of unknown 
etiology, but case studies show, that the sympathetic 
nervous system contributes to the abnormalities pres-
ent in CFS. American doctors want to treat CFS as 
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a separate disease. In Europe (also in Poland) another 
approach is dominating. Some clinicians suggest that 
it is not obvious that CFS can be distinguished from 
depression. The investigators hypothesize that sympa-
thetic activation underlies the patho-physiology of this 
disease, so the diagnosis should be confirmed using a 
special device for non-invasive examination of the car-
diovascular system and functional assessment of the 
auto-nomic nervous system.
 
2. Materials and methods
2.1 Patient characteristics
A 57-year-old patient (anthropometric data presented in 
Table 1) was referred as a volunteer to the Department 
of Chronomedicine and Functional Examination of the 
Autonomic Nervous 
 System of the Ludwik Rydygier Collegium Medicum 
in Bydgoszcz, Nicolaus Copernicus University in Torun. 
The patient described excessive daily sleepiness, sleep 
deprivation, fa-tigue, irritability, headache, and problems 
with concentration and memory. The patient report-ed 
that she easily falls asleep during monotonous activi-
ties (e.g. watching television, reading a book, or writ-
ing). Also, she experienced one episode of falling asleep 
while driving a car; fortunately, this did not result in an 
accident. At the first visitance, comprehensive interview 
and examinations were conducted to exclude potential 
comorbidities manifesting with chronic fatigue.
2.1.1 Identifying other causes of chronic fatigue
During the interview the patient did not report symptoms 
such as night dyspnea, chest pain, heart palpitations, 
nocturia, or dry mouth after waking up. Furthermore, 
she slept well at night, and did not snore according to 
her family members.
 Prior to the referral to the Department of Chronomedi-
cine and Functional Examination of the Autonomic Ner-
vous System, the patient was subjected to polysomno-
graphic examination, including electroencephalography 
(EEG), electrooculography (EOG), electromyography 
(EMG), as well as recording of chest, abdomen, and limb 
movements, body position, air flow, and snoring; the ex-
amination excluded the presence of obstructive apnea.
 According to the patient, she had not been diag-
nosed with comorbidities associated with per-sistent 
fatigue and excessive sleepiness, such as depression, 
hepatitis C, endocrine disorders, malignant disease, 
chronic pulmonary conditions, or cardiologic, gastro-
intestinal, liver, kidney, hematological, and mental dis-
orders. Furthermore, the patient did not take any long-
term medications.
 As a result of residing in a close proximity of a for-
est, Lyme disease was suspected. Although the patient 
had a history of numerous tick bites, no erythematous 
lesions were documented. Serological examination 
revealed 60.3 BBU/ml of anti-Borrelia burgdorferi IgG 
(positive result). Therefore the patient was referred to 
hospital for further evaluation. However, the result of 
reference recolLine test for anti-Borrelia burgdorferi IgG 
proved negative, similar to the examination of cerebro-
spinal fluid where 4.8 BBU/ml of anti-Borrelia burgdor-
feri IgG suggested the lack of neuroborreliosis.
 Additionally, comprehensive laboratory tests were 
ordered (Table 2, 3, 4) to exclude po-tential comorbidi-
ties. Aside from slightly elevated total cholesterol, all 
tested parameters proved normal.
2.1.2 Experimental scales
The patient completed the measure of excessive day-
time sleepiness the Epworth Sleepiness Scale (ESS) at 
the Department of Chronomedicine and Functional Ex-
amination of the Auto-nomic Nervous System. Exces-
sive daily sleeping was revealed (15 points). The ques-
tionnaire asks the subject about probability of falling 
asleep on a scale from 0 to 3 for eight daily life situations 
(result under 10 points - lack of the exaggerated sleepi-
ness, result above 14 points - pathological sleepiness).
Feature Value
 Age 57
 Height (cm) 158
 Body weight (kg) 70
 Body mass index (kg/m2) 28
 Indicator of the surface of the body (m2) 1,716
Table 1. Anthropometric data.
Biochemistry Result Unit Norm
Glucose 103 mg/dl 60 - 110
Serum creatinine 0.73 mg/dl 0.5 – 0.9
eGFR (MDRD) 88 ml/min/1.73 > 80
Total bilirubin 0.35 mg/dl 0.2 – 1
Alat 19 U/l < 31
Sodium 137 mmol/l 135 – 147
Potassium 4.16 mmol/l 3.7 – 5.1
Total Cholesterol 210 ↑ mg/dl 120 - 200
HDL Cholesterol 67 mg/dl > 65
% HDL Cholesterol 32 % > 20
LDL Cholesterol 125 mg/dl < 130
Triglycerides 94 mg/dl 50 – 150
Table 2. Results of the laboratory tests – biochemistry.
Immunology Result Unit Norm
TSH 3.670 µIU/ml 0.27 – 4.2
Table 3. Results of the laboratory tests – immunology.
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Moreover, as the patient suffered from persistent fa-
tigue, which was present for at least six months, was not 
substantially relieved by rest, and did not occur in the 
past (major symptom), and reported disorders of mem-
ory and concentration, sore throat, muscular pain, and 
headache of a new kind (four minor symptoms), she was 
examined for the presence of chronic fatigue syndrome 
according to the criteria proposed by Fukuda  et al. 
 The patient scored 86% in the Fatigue Severity 
Score (FSS), which examines the influence of fatigue 
on the activity, motivation, work, and family life.
 Other questionnaires were also used to estimate the 
level of fatigue in our patient; namely, a visual analogue 
scale (VAS). VAS is a simple method used to deter-
mine the level of subjec-tively assessed variables (e.g. 
fatigue), which cannot be precisely measured with any 
available objective method. The patient was presented 
with a scale consisting of a 10 cm “ruler” marked with 
smiling and sad emoticons at its ends and correspond-
ing to the lack of fatigue and severe fatigue, respectively 
(Figure 1). Next, the subject was asked to assess the 
severity of experienced fatigue in a numeric scale in 
which 0 and 10 corresponded to the lack of fatigue and 
extremely severe fatigue, respectively. The patient self-
assessed her fatigue as 8.
 The scales described above were chosen for the 
examination, because they are frequently used in as-
sessing patients with CFS and characterise an abnor-
mal condition of fatigue and sleepi-nesses in CFS. 
2.1.3 Examination at the Department of Chronomedi-
cine and Functional Examination of the Autonomic Ner-
vous System
In view of previous literature highlighting the role of au-
tonomic dysfunction in CFS, the pa-tient was offered 
functional examination of cardiovascular and auto-
nomic nervous systems with the Task Force Monitor 
(TFM) [5].
The examination took place under standard functional 
examination of the autonomic nervous system condi-
tions. Prior to the test, the patient rested for 15 minutes 
in a supine position. Dur-ing the examination, room 
temperature was approximately 21°C and the room 
was quiet and darkened. The test was conducted in the 
morning, two hours after the last meal.
 Verticalization was performed with a verticaliza-
tion table, equipped with stabilizing belts to provide 
patient’s safety. After reaching 70° decline, the patient 
remained in this position for 5 minutes prior to the de-
termination of cardiovascular parameters. Their values 
were compared to those recorded during the initial 
15-minute rest period.
 The patient did not report sensations such as verti-
go, seeing dark spots, tinnitus, headache, or dry mouth 
during the verticalization test.
 The following parameters were analysed: systolic 
blood pressure (sBP) [mmHg], diastolic blood pressure 
(dBP) [mmHg], mean blood pressure (mBP) [mmHg], 
stroke volume (SV) [ml], cardiac output (CO) [l/min]), 
heart rate (HR) [bmp], total peripheral resistance (TPR) 
[dyn*s/cm5], stroke index (SI) [ml/m2], cardiac index (CI) 
[L/min/m2], index of contractility (IC) [1000/s], Heath-
er index (HI) [1/s], and left ventricular ejection time 
(LVET) [ms]. 
 Additionally, the heart rate variability (HRV) param-
eters were examined, including normal-ized unit in low 
frequency domain HRV (LFnu-RRI) [%], normalized 
unit in high frequency domain HRV (HFnu-RRI) [%], 
low-frequency component of HRV spectrum (LF-
RRI) [ms2], high-frequency component of HRV spec-
trum (HF RRI) [ms2], power spectral density of HRV 
(PSD-RRI) [ms2], and sympathetic-vagal balance ratio 
(LF/HF; LF_RRI/HF_RRI). 
 Previous studies have suggested that these auto-
nomic and cardiovascular parameters have the poten-
tial as bedside diagnostic tools in CFS [6].
Blood count Result Unit Norm
WBC – white blood cells 5.7 X10^3/uL 4-10
LYMPH % 41.1 % 18-47.5
MXD% 5.3 % <10
NEUTH% 53.6 % 42.5-73
LYMPH 2.30 X10^3/uL
MXD 0.30 X10^3/uL
NEUTH 3.10 X10^3/uL
RBC – erythrocytes 4.49 X10^6/uL 3.8-5.2
HGB – haemoglobin 13.30 g/dl 11.5-16
HCT – hematocrit 38.90 % 36-47
MCV 86.60 fL 80-100
MCH 29.60 pg 28-34
MCHC 34.20 g/dl 32-36
PLT 211 X10^3/uL 140-440
RDW – SD 36.80 fL
PDW 11.80 fL
MPV 14.40 fL
P – LCR 28.00 %
Table 4. Results of the laboratory tests - haematology.
Figure 1. Visual Analogue Scale - VAS.
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3. Results
The passive verticalization of our patient was reflected 
by a decrease in stroke volume (SV), along with a de-
crease in cardiac output (CO). Moreover, an increase 
in the heart rate was documented as compared to the 
baseline value determined during the 15-minute rest 
period (HR). Furthermore, the passive verticaliza-
tion was reflected by an increase in total peripheral 
resistance (TPR), systolic blood pressure (sBP), dia-
stolic blood pressure (dBP), and mean blood pres-
sure (mBP). 
 The autonomic dysfunction can be excluded on the 
basis of heart rate variability analysis. Low frequency 
(LF) and high frequency (HF) components can be de-
termined during spectral analysis. The LF/HF ratio re-
flects relative influence of sympathetic and parasympa-
thetic nervous system on the sinoatrial node.
 The passive verticalization of our patient was re-
flected by significant increase in LFnu-RRI, LF-RRI, 
PSD-RRI, and LF/HF power ratio, which suggests in-
creased sympathetic autonomic activity. The passive 
verticalization caused an increase in normalized unit 
in low frequency domain HRV (LFnu-RRI), with ac-
companying increase in the low-frequency component 
of HRV spectrum (LF-RRI). Additionally, an increase 
in the power spectral density of HRV (PSD-RRI) and 
sympathetic-vagal balance ratio value (LF/HF) was 
documented. The values of these parameters are pre-
sented in Tables 5, 6, and 7.
4. Discussion
Our patient experienced chronic fatigue for at least half 
a year in accordance with the defini-tion of chronic fa-
tigue syndrome as proposed by CDC and an interna-
tional study group. Sim-ultaneously, she experienced 
such symptoms as sleep deprivation, sore throat, 
lymphadenopa-thy, muscular and joint pain, non-local-
ized headaches of a new kind, and impaired memory 
and concentration. All these manifestations suggested 
the presence of chronic fatigue syn-drome.
 Additionally, we performed necessary laboratory 
tests, including complete blood count, uri-nalysis, ami-
notransferase activity, thyroid hormones levels, glu-
cose, urea, and creatinine, as well as accessory tests 
(polysomnographic examination, neuroborreliosis test), 
to exclude potential comorbidities manifesting with 
chronic fatigue. The results of all these tests were with-
in normal ranges. 
Variable
Statistics - examination 1
Mean Min. Max.
sBP 111.401 92.278 133.599
dBP 75.028 62.936 97.786
mBP 92.178 77.391 115.156
SV 86.167 65.387 103.844
CO 5.222 6.528 4.251
HR 60.801 52.861 80.053
TPR 1370.796 1077.893 1805.329
SI 50.209 38.101 60.509
CI 3.043 2.477 3.804
IC 58.74 14.662 98.308
HI 0.297 0.047 0.578
LVET 321.102 262.534 348.185
sBP – systolic Blood Pressure; dBP – diastolic Blood Pressure; 
mBP – mean Blood Pressure; SV – Stroke Volume; CO – Cardiac 
Output; HR – Heart Rate; TPR - Total Peripheral Resistance; SI - Stroke 
Index; CI – Cardiac Index; IC – Index of contractility; HI - Heather index; 
LVET - Left ventricular ejection time
Table 5. Descriptive statistics of parameters: sBP, dBP, SV, CO, HR, 
SI, CI, IC, HI, LVET and TPR (Examination 1).
Variable
Statistics - examination 2
Mean Min. Max
sBP 132.941 117.048 146.578
dBP 96.913 82.952 109.522
mBP 113.199 98.774 124.427
SV 63.748 52.481 78.301
CO 4.054 3.388 5.325
HR 63.71 54.15 81.008
TPR 2186.49 1676.215 2603.14
SI 37.145 30.58 45.625
CI 2.362 1.974 3.103
IC 36.807 1.227 67.675
HI 0.166 0.536 0.006
LVET 322.42 258.619 347.306
sBP – systolic Blood Pressure; dBP – diastolic Blood Pressure; 
mBP – mean Blood Pressure; SV – Stroke Volume; CO – Cardiac 
Output; HR – Heart Rate; TPR - Total Peripheral Resistance; SI - Stroke 
Index; CI – Cardiac Index; IC – Index of contractility; HI - Heather index; 
LVET - Left ventricular ejection time
Table 6. Descriptive statistics of parameters: sBP, dBP, SV, CO, HR, 
SI, CI, IC, HI, LVET and TPR (Examination 2).
Parameters Unit Mean value - lying Mean value – division
LFnu-RRI [%] 82.370 91.881
HFnu-RRI [%] 17.630 8.119
LF-RRI [ms2] 21.387 36.894
HF-RRI [ms2] 9.716 10.552
PSD-RRI [ms2] 30.481 46.584
LF/HF [1] 2.291 6.210
LFnu-RRI - normalized unit in low frequency domain HRV; 
HFnu-RRI - normalized unit in high frequency domain HRV; 
LF-RRI - low-frequency component of HRV spectrum; 
HF-RRI - high-frequency component of HRV spectrum; 
PSD-RRI - power spectral density of HRV; 
LF/HF – sympathetic - vagal balance ratio
Table 7. Parameters of the spectrum analysis of the heart rate 
variability analysis.
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 In addition, the patient was examined with the Task 
Force Monitor (TFM) system in order to assess the in-
tegrity of the cardiovascular and autonomic nervous 
systems. Previously pub-lished studies with vertical-
ization table revealed that chronic fatigue syndrome is 
associated with abnormalities of autonomic regulatory 
mechanisms. According to the literature, when com-
pared to the controls, many CFS patients are character-
ized by orthostatic disorders and lower blood pressure, 
both possibly resulting from the abnormal functioning of 
ANS. Howev-er, to date, this phenomenon has not been 
fully elucidated [5,7-10]. Using the Task Force Monitor 
might allow us to develop objective tools to diagnose 
CFS and perhaps allow us to diagnose it earlier. 
 The heart rate variability (HRV) parameters analy-
sis attempts to assess cardiac autonomic regulation 
through quantification of sinus rhythm variability and 
presents and allows early detection of irregularities of 
the autonomic nervous system. Further work is needed 
to answer the questions these findings raise [11,16].
 Due to the normal functioning of reflexes, the pas-
sive verticalization of healthy individuals is reflected 
by about 25% decrease in the stroke volume and 30% 
increase in both the heart rate and total peripheral re-
sistance. Orthostatic hypotonia is diagnosed if systolic 
or diastolic blood pressure decreases by 20 mmHg or 
10 mmHg, respectively, 3 minutes after passive verti-
cali-zation [12-14].
 Previous studies revealed the predominance of sym-
pathetic nervous system in the regulation of cardiovas-
cular function in CFS patients. Higher values of LF/HF 
ratio observed in chronic fatigue syndrome, both during 
the day and at night, suggest the impairment of sym-
pathetic-parasympathetic equilibrium in favour of the 
sympathetic nervous system. Our patient also showed 
higher value of LF/HF at rest, which was equal to 2.291 
(norm: 1-1.5).
 Moreover, a significant increase in LFnu-RRI, LF-
RRI, PSD-RRI, and LF/HF ratio was ob-served in our 
patient as a result of passive verticalization; this sug-
gests the activation of the sympathetic component. 
Although some authors suggest that the response of 
CFS patients to passive verticalization is similar to that 
of healthy individuals, it has been shown that the acti-
vation of the sympathetic nervous system can be more 
pronounced as was documented in our patient [15-23].
The evaluation of chronic fatigue syndrome remains 
challenging. Medical history is not suffi-cient to confirm 
or exclude CFS; additional tests are required to exclude 
other comorbidities. This is further hindered by the un-
explained etiology of chronic fatigue syndrome, which 
has been hotly debated and dramatically altered in the 
recent years. Theories of genetic, immuno-logical, and 
psychological background of CFS have been proposed; 
moreover, hormonal dis-orders or viral infection have 
also been suggested. A number of experts believe that 
Chronic Fatigue Syndrome develops from a combina-
tion of different factors such as: stress-related hormonal 
abnormalities, brain abnormalities. Abnormal levels of 
certain chemicals in the brain system known as the hy-
pothalamus-pituitary-adrenal (HPA) axis have been pro-
posed as a cause of CFS, because this system controls 
important functions like: the stress response, depres-
sion and sleep. CFS has sometimes been referred to 
as the “chronic fatigue immune dysfunction syndrome”, 
because a number of studies have found irregularities of 
the immune system. Recently, the role of abnormal au-
tonomic function in the pathogenesis of chronic fa-tigue 
syndrome has been investigated, suggesting potential 
significance in the diagnostic pro-cess of this condition 
in the future [24-29].
5. Conclusion
Currently there are no objective diagnostic tests for 
Chronic Fatigue Syndrome. This case shows, that the 
best diagnostic approach is to firstly determine whether 
the patient matches the diagnostic criteria for CFS in-
cluding ruling out other possible causes of symptoms. 
A number of studies, in addition to this case report, have 
highlighted irregularities of the auto-nomic nervous sys-
tem in cases with CFS. Stimulation of the sympathetic 
nervous system through analysis of the heart rate vari-
ability (HRV) parameters appears to potential important 
element in the CFS diagnosis. The Task Force Monitor 
has a role to play in the objective di-agnosis of auto-
nomic nervous system abnormalities in CFS. Further 
research explaining auto-nomic disorders in CFS is 
necessary to improve the diagnostic protocol of Chronic 
Fatigue Syndrome. 
 Currently, CFS appears to be infrequently diagnosed 
in Poland.  It is unlikely to be because it is less common 
in Poland but rather that it is underrecognised.  CFS is 
a debilitating condition that impacts significantly upon 
quality of life, recognising and managing it are impor-
tant steps towards understanding how common it is in 
Poland and what services might be needed for those 
affected.
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